Objective: To test the hypothesis that ovarian hormones in women with
hyperandrogenism alter adrenocortical steroidogenesis. Design: Combina
tion of two prospective studies. Setting: Academic medical centers. Pa
tient(s): Eighteen hyperandrogenic patients demonstrating hirsutism wi
th either hyperandrogenemia, oligomenorrhea, or both. Eighteen healthy
nonhirsute eumenorrheic untreated women served as controls. Intervent
ions: Blood sampling basally and after acute adrenal stimulation with
ACTH, before and after 30-24 weeks of leuprolide administration. Nine
patients also received 0.625 mg/d of oral conjugated esterified estrog
ens and 10 mg of medroxyprogesterone acetate days 1-12 of the month (i
.e., estrogen replacement therapy [ERT]), whereas the remaining nine d
id not. Main Outcome Measure(s): Before and after the administration o
f the GnRH agonist (GnRH-a), the basal concentrations of DHEAS; and th
e levels of androstenedione (A4), DHEA, androstenediol, 11 beta-hydrox
yandrostenedione (11-OHA4), and cortisol before and 60 minutes after a
cute adrenal stimulation, were measured.Result(s): Levels of DHEAS, an
drostenediol, and 11-OHA4 decreased by 15%-30%, regardless of whether
patients initially had or did not have DHEAS excess. However, only hyp
erandrogenic patients with elevated levels of DHEAS showed a significa
nt decrease in basal DHEA levels. No statistically significant differe
nce in the response of either androgen to ACTH (1-24) stimulation was
noted with ovarian suppression, regardless of initial DHEAS level or u
se of ERT. Conclusion(s): We found no evidence that ovarian hormone se
cretion affected adrenal steroidogenesis, and those women with the hig
hest adrenal androgen levels had the least response to GnRH-a suppress
ion. These findings further support the concept of an intrinsic, and p
ossibly primary, abnormality of adrenocortical steroidogenesis in a su
bset of hyperandrogenic women that is independent of ovarian abnormali
ties. (C) 1998 by American Society for Reproductive Medicine.